LONDON (Reuters) - Britain’s medicines advisory agency is now planning to publish its latest recommendations on the cost-effectiveness of drug-coated stents late next week, in a decision that could draw fire from manufacturers. A spokesman for the National Institute for Health and Clinical Excellence (NICE) said on Wednesday the announcement is scheduled for late in the week beginning January 28. The decision, which had been expected before then, will be published on the agency’s Web site.
